Progress Toward Implementation of Human Papillomavirus Vaccination - the Americas, 2006-2010

Cervical cancer is a major cause of morbidity and mortality in the Americas, where an estimated 80,574 new cases and 36,058 deaths were reported in 2008, with 85% of this burden occurring in Latin America and the Caribbean. Two oncogenic human papillomavirus (HPV) types cause approximately 70% of ce...

Full description

Saved in:
Bibliographic Details
Published in:MMWR. Morbidity and Mortality Weekly Report 2011, Vol.60 (40), p.1382
Main Authors: Vicari, Andrea S, Dilsa, Lara G, Deeks, Shelley, Mireles, Susana P Cerón, San Román, Mirella Loustalot Laclette, Romero, Raquel Espinosa, Mulato, Maria del Carmen Domínguez, López-Collada, Vesta Richardson, de Moltó, Yadira, de Hewitt, Itzel S, Saraiya, Mona, Hyde, Terri, Markowitz, Lauri E, Dunne, Eileen F, Meites, Elissa, Surie, Diya
Format: Report
Language:English
Subjects:
Disease prevention
Human papillomavirus
Immunization
Public health
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Cervical cancer is a major cause of morbidity and mortality in the Americas, where an estimated 80,574 new cases and 36,058 deaths were reported in 2008, with 85% of this burden occurring in Latin America and the Caribbean. Two oncogenic human papillomavirus (HPV) types cause approximately 70% of cervical cancers and a substantial proportion of other HPV-related cancers. Vicari et al summarize the progress toward HPV vaccine introduction in the Americas, focusing on countries that have introduced the vaccine in national or regional immunization programs. A CDC editorial note is presented.
ISSN:0149-2195
1545-861X